Pharma

Your Article Summary

See Latest Articles

Copy-number variation: the end of the human genome
Trends in Biotechnology , 07/30/09

Dear PH – This article will present a somewhat biased and occasionally speculative discussion of the current and future significance of CNV with a particular focus on the potential of molecular copy–number counting in the analysis of small, damaged or heterogeneous samples.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

 See all of Biotechnology